Keppra Interactions Checker
Serum levels of TSH were lower under the oral solution compared with the tablet both in the replacement group (1.63 ± 0.66mU/l vs. 2.77 ± 2.05 mU/l) and in the suppressive group (0.12 ± 0.12 mU/l vs.1.15 ± 1.85 mU/l). The aim of this study was to assess the effect of concomitant use of levothyroxine (LT4) and proton pump inhibitors (PPIs) on thyroid-stimulating hormone (TSH) levels in patients with primary hypothyroidism. Using multivitamin with minerals together with levothyroxine may decrease the effects of levothyroxine. You should separate the administration of levothyroxine and multivitamin with minerals by at least 4 hours. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. Mangaiarkkarasi Adhimoolam contributed in the idea of research, study design, data collection, data analysis and manuscript preparation with literature analysis.
Related treatment guides
This will help you and your doctors to evaluate all possible interactions and come up with a plan to avoid or minimize them. Completed the searching and screening of literature and data extraction. Gave the methodological guidance and writing guidance throughout the process. Each author contributed to the article and approved the submitted version. Alcohol can increase the nervous system side effects of levETIRAcetam such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment.
Practice Update: Review of Anticonvulsant Therapy
- This effect could be much evident in subjects in whom LT4 absorption is already impaired for other reasons.
- Epilepsy is a chronic disease and its treatment is lifelong in one-third of patients.
- Gray literature was also searched in repositories, websites OpenGrey and Google Scholar, and abstracts of major international congresses.
- The liver enzyme inducing antiepileptic drugs (EIAEDs), like phenobarbital, phenytoin, and carbamazepine, and also valproate (VPA), a non-EIAED, are most likely to cause such side effects.
- Lamotrigine has not been shown to result in endocrine side effects.
In fact, it is recommended to separate the administration of these medicines from levothyroxine by 4 hours. Each of the included studies showed an increase in TSH levels following LT4 and PPI consumption and in the majority of these, the increase was statistically significant. This effect could be much evident in subjects in whom LT4 absorption is already impaired for other reasons.
A hospital-based, analytical cross-sectional study was conducted among the adult epileptic patients receiving conventional AEDs (Group 2) or newer AEDs (Group 3) for more than 6 months. Serum thyroid hormone levels including free triiodothyronine (fT3), free thyroxine (fT4), and thyroid stimulating hormone (TSH) were analyzed and the hormonal status was compared with healthy control subjects (Group 1). A systematic search of databases, PubMed, EMBASE, Web of Science, and the Cochrane Library, was conducted and all observational studies reporting thyroid hormone levels in epilepsy patients receiving monotherapy and controls were included. It is noteworthy that in two studies37,38 patients were switched from the tablet formulation to the liquid one while maintaining the co-ingestion of PPI and the daily dose of LT4, with a significant decrease in serum TSH levels (Table 1). Sometimes drug interactions cannot be avoided because both medicines may be very important to your treatment.
However, this finding should be interpreted with caution due to the limited number of studies with relatively short follow-up period and lack of robust statistical evidence. Well-designed large studies are needed in order to further better clarify the interfering role of PPI on LT4 intestinal absorption. Saraceno et al.37 carried out a crossover study in 15 patients on LT4, 6 of them on replacement therapy and 9 on TSH-suppressive therapy, who were receiving PPI. The patients switched from the tablet to the oral solution of LT4.
Drug Interactions between Keppra and Synthroid
This review focuses on the evidence, mechanisms of thyroid abnormalities with AEDs and their clinical implications. The associations between subclinical hypothyroidism and metabolic risks due to AEDs are also discussed. Therefore, the results of this systematic review were summarized qualitatively. A systematic review of interventional and observational studies that compared the TSH levels before and after concomitant use of LT4 and PPI was performed. Articles published in English up to September 1, 2019, were included. Gray literature was also searched in repositories, websites OpenGrey and Google Scholar, and abstracts of major international congresses.
Literature Search
Following assessment and application of eligibility criteria, seven studies were included. There was a considerable heterogeneity among the included studies in design, sample size, inclusion and exclusion criteria, treatment regimen, and baseline demographics. Each of the included studies showed an increase in TSH levels following LT4 and PPI consumption, and in the majority of these, the increase was statistically significant. In the preliminary search, 5012 studies were identified through the literature search, and 2004 remained after the duplicates were removed. A title and abstract review was performed on the remaining 2004 studies, with 1983 excluded at this first stage for not meeting the PICOS criteria. A PRISMA flow diagram of the screening and selection process can be found in Figure 1.
Drug Interactions between Keppra and levothyroxine
Thyroid abnormalities were reported in one-third of the patients on AEDs. All reported patients were clinically euthyroid and hormonal changes were reversible after AED withdrawal. The mechanisms for thyroid dysfunction with AEDs include enhanced metabolism and/or altered protein binding or interference of hypothalamic-pituitary-thyroid axis function.
However, given the small number of studies, further synthroid belching research is needed to clarify the interfering role of PPI on LT4 intestinal absorption. All data analyzed during the study are included in this published version. Levothyroxine is a man-made form of the human thyroid hormone called T4. It is given to people who do not produce enough of their own thyroid hormone (hypothyroidism). Add your drug list to My Med List to view medical information in a simple, easy-to-read, personalized format.
EIAEDs increase sex hormone binding globulin (SHBG) concentrations in both men and women. Over time, this elevation can lead to lower levels of bioactive testosterone and estradiol, which may cause menstrual disturbances, sexual problems, and eventually reduced fertility. In women, VPA can also lead to androgenization with increased serum testosterone concentrations, menstrual disturbances, and polycystic ovaries.
